986 related articles for article (PubMed ID: 32164470)
1. Microneedles as an alternative technology for transdermal drug delivery systems: a patent review.
Queiroz MLB; Shanmugam S; Santos LNS; Campos CA; Santos AM; Batista MS; Araújo AAS; Serafini MR
Expert Opin Ther Pat; 2020 Jun; 30(6):433-452. PubMed ID: 32164470
[No Abstract] [Full Text] [Related]
2. Current trends in polymer microneedle for transdermal drug delivery.
Ahmed Saeed Al-Japairai K; Mahmood S; Hamed Almurisi S; Reddy Venugopal J; Rebhi Hilles A; Azmana M; Raman S
Int J Pharm; 2020 Sep; 587():119673. PubMed ID: 32739388
[TBL] [Abstract][Full Text] [Related]
3. A key role by polymers in microneedle technology: a new era.
Rajput A; Kulkarni M; Deshmukh P; Pingale P; Garkal A; Gandhi S; Butani S
Drug Dev Ind Pharm; 2021 Nov; 47(11):1713-1732. PubMed ID: 35332822
[TBL] [Abstract][Full Text] [Related]
4. Microneedles: A smart approach and increasing potential for transdermal drug delivery system.
Waghule T; Singhvi G; Dubey SK; Pandey MM; Gupta G; Singh M; Dua K
Biomed Pharmacother; 2019 Jan; 109():1249-1258. PubMed ID: 30551375
[TBL] [Abstract][Full Text] [Related]
5. Advances in microneedle-based transdermal delivery for drugs and peptides.
Aich K; Singh T; Dang S
Drug Deliv Transl Res; 2022 Jul; 12(7):1556-1568. PubMed ID: 34564827
[TBL] [Abstract][Full Text] [Related]
6. Microneedles: an emerging transdermal drug delivery system.
Bariya SH; Gohel MC; Mehta TA; Sharma OP
J Pharm Pharmacol; 2012 Jan; 64(1):11-29. PubMed ID: 22150668
[TBL] [Abstract][Full Text] [Related]
7. Review of patents for microneedle application devices allowing fluid injections through the skin.
Lhernould MS; Tailler S; Deleers M; Delchambre A
Recent Pat Drug Deliv Formul; 2015; 9(2):146-57. PubMed ID: 25770583
[TBL] [Abstract][Full Text] [Related]
8. Microneedles for transdermal drug delivery: a minireview.
Vandervoort J; Ludwig A
Front Biosci; 2008 Jan; 13():1711-5. PubMed ID: 17981662
[TBL] [Abstract][Full Text] [Related]
9. Dissolving microneedles: Applications and growing therapeutic potential.
Sartawi Z; Blackshields C; Faisal W
J Control Release; 2022 Aug; 348():186-205. PubMed ID: 35662577
[TBL] [Abstract][Full Text] [Related]
10. Optimizing microneedle arrays to increase skin permeability for transdermal drug delivery.
Al-Qallaf B; Das DB
Ann N Y Acad Sci; 2009 Apr; 1161():83-94. PubMed ID: 19426308
[TBL] [Abstract][Full Text] [Related]
11. Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin.
Liu S; Jin MN; Quan YS; Kamiyama F; Kusamori K; Katsumi H; Sakane T; Yamamoto A
Eur J Pharm Biopharm; 2014 Feb; 86(2):267-76. PubMed ID: 24120887
[TBL] [Abstract][Full Text] [Related]
12. Microneedles for transdermal drug delivery.
Prausnitz MR
Adv Drug Deliv Rev; 2004 Mar; 56(5):581-7. PubMed ID: 15019747
[TBL] [Abstract][Full Text] [Related]
13. Current advances in the fabrication of microneedles for transdermal delivery.
Indermun S; Luttge R; Choonara YE; Kumar P; du Toit LC; Modi G; Pillay V
J Control Release; 2014 Jul; 185():130-8. PubMed ID: 24806483
[TBL] [Abstract][Full Text] [Related]
14. Optimizing microneedle arrays for transdermal drug delivery: extension to non-square distribution of microneedles.
Al-Qallaf B; Das DB
J Drug Target; 2009 Feb; 17(2):108-22. PubMed ID: 19016071
[TBL] [Abstract][Full Text] [Related]
15. Spatially controlled coating of continuous liquid interface production microneedles for transdermal protein delivery.
Caudill CL; Perry JL; Tian S; Luft JC; DeSimone JM
J Control Release; 2018 Aug; 284():122-132. PubMed ID: 29894710
[TBL] [Abstract][Full Text] [Related]
16. Advanced Compounding: Compounding with Microneedle Arrays, Part 3: Microneedle Array Development in the Literature and Quality Control of Microneedle Arrays.
Allen LV
Int J Pharm Compd; 2023; 27(1):30-37. PubMed ID: 36720061
[TBL] [Abstract][Full Text] [Related]
17. Nanoemulsion-based dissolving microneedle arrays for enhanced intradermal and transdermal delivery.
Nasiri MI; Vora LK; Ershaid JA; Peng K; Tekko IA; Donnelly RF
Drug Deliv Transl Res; 2022 Apr; 12(4):881-896. PubMed ID: 34939170
[TBL] [Abstract][Full Text] [Related]
18. Microneedle-Mediated Transdermal Delivery of Bevacizumab.
Courtenay AJ; McCrudden MTC; McAvoy KJ; McCarthy HO; Donnelly RF
Mol Pharm; 2018 Aug; 15(8):3545-3556. PubMed ID: 29996645
[TBL] [Abstract][Full Text] [Related]
19. Microneedle-based drug delivery: studies on delivery parameters and biocompatibility.
Wu Y; Qiu Y; Zhang S; Qin G; Gao Y
Biomed Microdevices; 2008 Oct; 10(5):601-10. PubMed ID: 18324474
[TBL] [Abstract][Full Text] [Related]
20. Enhanced skin drug delivery using dissolving microneedles: a potential approach for the management of skin disorders.
Priya S; Tomar Y; Desai VM; Singhvi G
Expert Opin Drug Deliv; 2023 Jun; 20(6):721-738. PubMed ID: 36893450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
